LENZ
LENZ Therapeutics
LENZ
LENZ
166 hedge funds and large institutions have $1.36B invested in LENZ Therapeutics in 2025 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 65 increasing their positions, 22 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
47% more funds holding
Funds holding: 113 → 166 (+53)
14.32% more ownership
Funds ownership: 87.85% → 102.17% (+14%)
70% less call options, than puts
Call options by funds: $1.96M | Put options by funds: $6.51M
Holders
166
Holding in Top 10
9
Calls
$1.96M
Puts
$6.51M
Top Buyers
| 1 | +$124M | |
| 2 | +$32.3M | |
| 3 | +$26.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$18.2M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.9M |
Top Sellers
| 1 | -$30M | |
| 2 | -$28.6M | |
| 3 | -$23.1M | |
| 4 |
Morgan Stanley
New York
|
-$13.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13M |
